SkyePharma seeks new capital for bond buyback
SkyePharma, the UK pharmaceutical company, is set to restructure its balance sheet with a big share issuance to be used to retire debt.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts